SPY317.59+3.21 1.02%
DIA260.82+3.58 1.39%
IXIC10,617.44+69.69 0.66%

HC Wainwright & Co. Maintains Buy on Verrica Pharmaceuticals, Lowers Price Target to $18

HC Wainwright & Co. analyst Oren Livnat maintains Verrica Pharmaceuticals (NASDAQ:VRCA) with a Buy and lowers the price target from $24 to $18.

Benzinga · -
HC Wainwright & Co. analyst Oren Livnat maintains Verrica Pharmaceuticals (NASDAQ: VRCA) with a Buy and lowers the price target from $24 to $18.